Cargando…

Advances in Immunotherapy for the Treatment of Adult Glioblastoma: Overcoming Chemical and Physical Barriers

SIMPLE SUMMARY: The poor prognosis for glioblastoma (GBM) despite the existence of a standard-of-care treatment of resection, radiotherapy, and adjuvant chemotherapy has necessitated the exploration of other therapeutic avenues. One particularly promising avenue is an immunotherapeutic approach in w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lechpammer, Mirna, Rao, Rohan, Shah, Sanjit, Mirheydari, Mona, Bhattacharya, Debanjan, Koehler, Abigail, Toukam, Donatien Kamdem, Haworth, Kevin J., Pomeranz Krummel, Daniel, Sengupta, Soma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997081/ https://www.ncbi.nlm.nih.gov/pubmed/35406398 http://dx.doi.org/10.3390/cancers14071627

Ejemplares similares

Ligand-Gated Ion Channels as Targets for Treatment and Management of Cancers
por: Rao, Rohan, et al.
Publicado: (2022)

Reuse of Molecules for Glioblastoma Therapy
por: Koehler, Abigail, et al.
Publicado: (2021)

Pediatric cerebellar tumors: transcriptionally distinct but developmentally heterogeneous
por: Bhattacharya, Debanjan, et al.
Publicado: (2020)

Advances in Focused Ultrasound for the Treatment of Brain Tumors
por: Rao, Rohan, et al.
Publicado: (2023)

The evolution of medulloblastoma therapy to personalized medicine
por: Sengupta, Soma, et al.
Publicado: (2017)

COVID-19 Vaccine Mandates for Healthcare Professionals in the United States
por: Rao, Rohan, et al.
Publicado: (2022)

Ligand-Gated Ion Channels: Prognostic and Therapeutic Implications for Gliomas
por: Hey, Grace, et al.
Publicado: (2023)

Overcoming delivery barriers in immunotherapy for glioblastoma
por: Rui, Yuan, et al.
Publicado: (2021)

Barriers to overcoming immunotherapy resistance in glioblastoma
por: Gillette, Julia S., et al.
Publicado: (2023)

A Case Study Using Papaya Leaf Extract to Reverse Chemotherapy-Induced Thrombocytopenia in a GBM Patient
por: Koehler, Abigail, et al.
Publicado: (2022)

Expression Levels and Localizations of DVL3 and sFRP3 in Glioblastoma
por: Kafka, Anja, et al.
Publicado: (2017)

20. MELANOMA CELL INTRINSIC GABAA RECEPTOR ENHANCEMENT POTENTIATES RADIATION AND IMMUNE CHECKPOINT INHIBITOR RESPONSE BY PROMOTING DIRECT AND T CELL-MEDIATED ANTI-TUMOR ACTIVITY
por: Sengupta, Soma, et al.
Publicado: (2020)

Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis
por: Bachir, Suha, et al.
Publicado: (2021)

Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment
por: Miyazaki, Tsubasa, et al.
Publicado: (2020)

Implicating Gene and Cell Networks Responsible for Differential COVID-19 Host Responses via an Interactive Single Cell Web Portal
por: Jin, Kang, et al.
Publicado: (2021)

An interactive single cell web portal identifies gene and cell networks in COVID-19 host responses
por: Jin, Kang, et al.
Publicado: (2021)

Current Advances in Immunotherapy for Glioblastoma
por: Mende, Abigail L., et al.
Publicado: (2021)

A rare case of centronuclear myopathy with DNM2 mutation: genotype–phenotype correlation
por: Aghbolaghi, Amir Ghorbani, et al.
Publicado: (2017)

Targeting Antibody Responses to the Membrane Proximal External Region of the Envelope Glycoprotein of Human Immunodeficiency Virus
por: Kamdem Toukam, Donatien, et al.
Publicado: (2012)

Structure of spliceosomal ribonucleoproteins
por: Krummel, Daniel Aaron Pomeranz, et al.
Publicado: (2010)

Molecular Genetics of Intracranial Meningiomas with Emphasis on Canonical Wnt Signalling
por: Pećina-Šlaus, Nives, et al.
Publicado: (2016)

Interleukin-13 Receptor Alpha 2-Targeted Glioblastoma Immunotherapy
por: Sengupta, Sadhak, et al.
Publicado: (2014)

Overcoming TRAIL Resistance for Glioblastoma Treatment
por: Deng, Longfei, et al.
Publicado: (2021)

Engineering nanoparticles to overcome barriers to immunotherapy
por: Toy, Randall, et al.
Publicado: (2016)

Immunotherapy biomarkers 2016: overcoming the barriers
por: Gulley, James L., et al.
Publicado: (2017)

Rapid discrimination of pediatric brain tumors by mass spectrometry imaging
por: Clark, Amanda R., et al.
Publicado: (2018)

Using triple radio-immunotherapy to overcome cancer immunotherapy resistance
por: Zhang, Zengfu, et al.
Publicado: (2023)

Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
por: JIAPAER, Shabierjiang, et al.
Publicado: (2018)

Delivering Therapeutics to Glioblastoma: Overcoming Biological Constraints
por: Mathew, Elza N., et al.
Publicado: (2022)

Immunotherapy Resistance in Glioblastoma
por: Wang, Elaina J., et al.
Publicado: (2021)

Chiral nematic liquid crystal microlenses
por: Popov, Piotr, et al.
Publicado: (2017)

Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth
por: Kondo, Keiichi, et al.
Publicado: (2003)

Hidden treasures: Incidental findings in two cases of chronic subdural hematoma
por: Ladenheim, Alexander, et al.
Publicado: (2022)

Overcoming some Limiting Factors in Tumour Immunotherapy
por: Fakhri, O., et al.
Publicado: (1973)

Nanotherapeutics Overcoming the Blood-Brain Barrier for Glioblastoma Treatment
por: Tang, Lin, et al.
Publicado: (2021)

Overcoming drug resistance in glioblastoma: new options in sight?
por: Kopecka, Joanna, et al.
Publicado: (2021)

Current Studies of Immunotherapy on Glioblastoma
por: Agrawal, Neena Stephanie, et al.
Publicado: (2014)

Advances in immunotherapy for the treatment of glioblastoma
por: Tivnan, Amanda, et al.
Publicado: (2016)

Virus-Based Immunotherapy of Glioblastoma
por: Martikainen, Miika, et al.
Publicado: (2019)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r3qcnl4qlfdtne8labicp4ah85